This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Japan, Lithuania, Poland, Singapore, Turkey, United States
The drug VIZAMYL contains one active pharmaceutical ingredient (API):
1
Flutemetamol ¹⁸F
UNII L49M066S0O - FLUTEMETAMOL F-18
|
Flutemetamol ¹⁸F binds to β-amyloid neuritic plaques in the brain. It is a radiopharmaceutical medicinal product indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. VIZAMYL should be used in conjunction with a clinical evaluation. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
VIZAMYL Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
V09AX04 | V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AX Other central nervous system diagnostic radiopharmaceuticals | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1662588, 1662599 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 114941002 |
Country: FR | Base de données publique des médicaments | Identifier(s): 67652999 |
Country: IT | Agenzia del Farmaco | Identifier(s): 043562014, 043562026 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 43004A4A1028 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1073834, 1073835 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100326514 |
Country: SG | Health Sciences Authority | Identifier(s): 15441P |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699360730355 |
Country: US | FDA, National Drug Code | Identifier(s): 17156-067 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.